Literature DB >> 26597985

The Vaccine Candidate Substrate Binding Protein SBP2 Plays a Key Role in Arginine Uptake, Which Is Required for Growth of Moraxella catarrhalis.

Taketo Otsuka1, Charmaine Kirkham1, Aimee Brauer1, Mary Koszelak-Rosenblum2, Michael G Malkowski2, Timothy F Murphy3.   

Abstract

Moraxella catarrhalis is an exclusively human pathogen that is an important cause of otitis media in children and lower respiratory tract infections in adults with chronic obstructive pulmonary disease. A vaccine to prevent M. catarrhalis infections would have an enormous global impact in reducing morbidity resulting from these infections. Substrate binding protein 2 (SBP2) of an ABC transporter system has recently been identified as a promising vaccine candidate antigen on the bacterial surface of M. catarrhalis. In this study, we showed that SBP1, -2, and -3 individually bind different basic amino acids with exquisite specificity. We engineered mutants that each expressed a single SBP from this gene cluster and showed in growth experiments that SBP1, -2, and -3 serve a nutritional function through acquisition of amino acids for the bacterium. SBP2 mediates uptake of arginine, a strict growth requirement of M. catarrhalis. Adherence and invasion assays demonstrated that SBP1 and SBP3 play a role in invasion of human respiratory epithelial cells, consistent with a nutritional role in intracellular survival in the human respiratory tract. This work demonstrates that the SBPs of an ABC transporter system function in the uptake of basic amino acids to support growth of M. catarrhalis. The critical role of SBP2 in arginine uptake may contribute to its potential as a vaccine antigen.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26597985      PMCID: PMC4730574          DOI: 10.1128/IAI.00799-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

Review 1.  A structural classification of substrate-binding proteins.

Authors:  Ronnie P-A Berntsson; Sander H J Smits; Lutz Schmitt; Dirk-Jan Slotboom; Bert Poolman
Journal:  FEBS Lett       Date:  2010-04-20       Impact factor: 4.124

2.  Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis.

Authors:  Hartmut Grasemann; Suhail Al-Saleh; Jeremy A Scott; Darakhshanda Shehnaz; Anne Mehl; Reshma Amin; Mahroukh Rafii; Paul Pencharz; Jaques Belik; Felix Ratjen
Journal:  Am J Respir Crit Care Med       Date:  2011-01-28       Impact factor: 21.405

3.  Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen.

Authors:  Min Yang; Antoinette Johnson; Timothy F Murphy
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

4.  Use of multiplex PCR for simultaneous detection of four bacterial species in middle ear effusions.

Authors:  P H Hendolin; A Markkanen; J Ylikoski; J J Wahlfors
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

Review 5.  Panel 6: Vaccines.

Authors:  Stephen I Pelton; Melinda M Pettigrew; Stephen J Barenkamp; Fabrice Godfroid; Carlos G Grijalva; Amanda Leach; Janak Patel; Timothy F Murphy; Sanja Selak; Lauren O Bakaletz
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

6.  Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.

Authors:  Elizabeth A Ruckdeschel; Aimee L Brauer; Antoinette Johnson; Timothy F Murphy
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

Review 7.  Moraxella catarrhalis: from interactions with the host immune system to vaccine development.

Authors:  Yu-Ching Su; Birendra Singh; Kristian Riesbeck
Journal:  Future Microbiol       Date:  2012-09       Impact factor: 3.165

8.  One third of middle ear effusions from children undergoing tympanostomy tube placement had multiple bacterial pathogens.

Authors:  Robert C Holder; Daniel J Kirse; Adele K Evans; Timothy R Peters; Katherine A Poehling; W Edward Swords; Sean D Reid
Journal:  BMC Pediatr       Date:  2012-06-28       Impact factor: 2.125

9.  A role for both conformational selection and induced fit in ligand binding by the LAO protein.

Authors:  Daniel-Adriano Silva; Gregory R Bowman; Alejandro Sosa-Peinado; Xuhui Huang
Journal:  PLoS Comput Biol       Date:  2011-05-26       Impact factor: 4.475

Review 10.  From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases.

Authors:  Dariusz Zakrzewicz; Oliver Eickelberg
Journal:  BMC Pulm Med       Date:  2009-01-29       Impact factor: 3.317

View more
  6 in total

Review 1.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

2.  A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Antoinette Johnson; Gregory E Wilding; Mary Koszelak-Rosenblum; Michael G Malkowski
Journal:  Clin Vaccine Immunol       Date:  2017-09-05

Review 3.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 4.  Panel 8: Vaccines and immunology.

Authors:  Mark R Alderson; Tim Murphy; Stephen I Pelton; Laura A Novotny; Laura L Hammitt; Arwa Kurabi; Jian-Dong Li; Ruth B Thornton; Lea-Ann S Kirkham
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-12-18       Impact factor: 1.675

5.  ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence.

Authors:  Timothy F Murphy; Aimee L Brauer; Antoinette Johnson; Charmaine Kirkham
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

6.  MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies.

Authors:  Evgeny A Semchenko; Christopher J Day; Kate L Seib
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.